Berry S - Search Results

1

Interim Analysis of the Phase II Study: Noninferiority Study of Doxorubicin with Upfront Dexrazoxane plus Olaratumab for Advanced or Metastatic Soft-Tissue Sarcoma.

Van Tine BA, Hirbe AC, Oppelt P, Frith AE, Rathore R, Mitchell JD, Wan F, Berry S, Landeau M, Heberton GA, Gorcsan J 3rd, Huntjens PR, Soyama Y, Vader JM, Alvarez-Cardona JA, Zhang KW, Lenihan DJ, Krone RJ. Van Tine BA, et al. Among authors: berry s. Clin Cancer Res. 2021 Jul 15;27(14):3854-3860. doi: 10.1158/1078-0432.CCR-20-4621. Epub 2021 Mar 25. Clin Cancer Res. 2021. PMID: 33766818 Free PMC article. Clinical Trial.

2

A Phase II Study of Tumor Ablation in Patients with Metastatic Sarcoma Stable on Chemotherapy.

Hirbe AC, Jennings J, Saad N, Giardina JD, Tao Y, Luo J, Berry S, Toeniskoetter J, Van Tine BA. Hirbe AC, et al. Among authors: berry s. Oncologist. 2018 Jul;23(7):760-e76. doi: 10.1634/theoncologist.2017-0536. Epub 2018 Feb 27. Oncologist. 2018. PMID: 29487221 Free PMC article. Clinical Trial.

3

Phase II study of dacarbazine given with modern prophylactic anti-emetics and growth factor support to patients with metastatic, resistant soft tissue, and bone sarcoma.

Van Tine BA, Weiss MC, Hirbe AC, Oppelt PJ, Abaricia S, Trinkaus K, Luo J, Berry S, Ruff T, Callahan C, Toensikoetter J, Ley J, Siegel MJ, Dehdashti F, Siegel BA, Adkins DR. Van Tine BA, et al. Among authors: berry s. Rare Tumors. 2021 Oct 8;13:20363613211052498. doi: 10.1177/20363613211052498. eCollection 2021. Rare Tumors. 2021. PMID: 34646430 Free PMC article.

4

Comparative safety and cardiovascular effectiveness of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists in nursing homes.

Riester MR, Zullo AR, Joshi R, Daiello LA, Hayes KN, Ko D, Kim DH, Munshi M, Berry SD. Riester MR, et al. Among authors: berry sd. Diabetes Obes Metab. 2024 May 23. doi: 10.1111/dom.15682. Online ahead of print. Diabetes Obes Metab. 2024. PMID: 38779879

5

Understanding patient, caregiver, and healthcare provider perspectives of the management of long-chain fatty acid oxidation disorders.

Baker ES, Botham J, Rechisky T, Romano E, Garcia D, Berry SA. Baker ES, et al. Among authors: berry sa. Ther Adv Rare Dis. 2024 May 20;5:26330040241252448. doi: 10.1177/26330040241252448. eCollection 2024 Jan-Dec. Ther Adv Rare Dis. 2024. PMID: 38778875 Free PMC article. Review.

6

Survival outcomes in head and neck squamous cell carcinoma of unknown primary: A national cohort study.

Hardman JC, Constable J, Dobbs S, Hogan C, Hulse K, Khosla S, Milinis K, Tudor-Green B, Williamson A, Paleri V; INTEGRATE (The UK ENT Trainee Research Network). Hardman JC, et al. Clin Otolaryngol. 2024 May 20. doi: 10.1111/coa.14167. Online ahead of print. Clin Otolaryngol. 2024. PMID: 38766691

7

Estimating the Proportion of People Living With HIV Who May Benefit From the Reverse Algorithm for the Diagnosis of Incident Syphilis.

Menza TW, Berry SA, Dombrowski JC, Cachay E, Crane HM, Mayer KH. Menza TW, et al. Among authors: berry sa. Sex Transm Dis. 2024 Jun 1;51(6):e26-e29. doi: 10.1097/OLQ.0000000000001955. Sex Transm Dis. 2024. PMID: 38733975

8

Effects of a personalized nutrition program on cardiometabolic health: a randomized controlled trial.

Bermingham KM, Linenberg I, Polidori L, Asnicar F, Arrè A, Wolf J, Badri F, Bernard H, Capdevila J, Bulsiewicz WJ, Gardner CD, Ordovas JM, Davies R, Hadjigeorgiou G, Hall WL, Delahanty LM, Valdes AM, Segata N, Spector TD, Berry SE. Bermingham KM, et al. Among authors: berry se. Nat Med. 2024 May 8. doi: 10.1038/s41591-024-02951-6. Online ahead of print. Nat Med. 2024. PMID: 38714898

9

Optimal sample size division in two-stage seamless designs.

Berry LR, Marion J, Berry SM, Viele K. Berry LR, et al. Among authors: berry sm. Pharm Stat. 2024 Apr 27. doi: 10.1002/pst.2394. Online ahead of print. Pharm Stat. 2024. PMID: 38676420

10

Are asymptomatic carriers of OTC deficiency always asymptomatic? A multicentric retrospective study of risk using the UCDC longitudinal study database.

Sen K, Izem R, Long Y, Jiang J, Konczal LL, McCarter RJ; Members of the Urea Cycle Disorders Consortium (UCDC); Gropman AL, Bedoyan JK. Sen K, et al. Mol Genet Genomic Med. 2024 Apr;12(4):e2443. doi: 10.1002/mgg3.2443. Mol Genet Genomic Med. 2024. PMID: 38634223 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,882 results

Search Page